Prescribing preferences and availability of nebulizers and inhalers for inhaled medications in bronchiectasis: results of a specialist survey

Footnotes

This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.

Conflict of interest: Pieter Goeminne reports lectures fees from Insmed, RMEI, and GSK, outside the submitted work; Support to attend conference from Chiesi, outside the submitted work; Participation on a Data Safety Monitoring Board or Advisory Board for Boehringer, GSK, and Pfizer, outside the submitted work.

Conflict of interest: Arietta Spinou has nothing to disclose.

Conflict of interest: Megan Crichton reports consulting fees from Boxer Capital LLC, outside the submitted work.

Conflict of interest: Charles Haworth reports consulting fees from 30 Technology, Aradigm, CSL Behring, Chiesi, Gilead, Grifols, GSK, Insmed, Janssen, LifeArc, Meiji, Mylan, Novartis, Pneumagen, Shionogi, Teva, Vertex and Zambon, outside the submitted work; Payment for lectures, presentations, speakers bureaus, manuscript writing or educational events from Chiesi, and Insmed, outside the submitted work.

Conflict of interest: Michal Shteinberg reports grants or contracts from GSK, Trudell medical international, and Tel Aviv league for lung diseases, outside the submitted work; Personal payments for consultations from Astra Zeneca, Boehringer Ingelheim, Dexcel, Kamada, Synchrony medical, Trumed, and Zambon, outside the submitted work; Payment for lectures, presentations, speakers bureaus, manuscript writing or educational events from Astra Zeneca, Boehringer Ingelheim, Kamada, Sanofi, and Insmed, outside the submitted work; Support for attending meetings and/or travel Boehringer Ingelheim Israel, Astra Zeneca Israel, Kamada, Rafa, and GSK Israel, outside the submitted work; Participation on a Data Safety Monitoring Board or Advisory Board Bonus Biotherapeutics, Boehringer Ingelheim, and Astra Zeneca, outside the submitted work; AJRCCM Associate Editor, Management board member: Israeli Pulmonology society, Israeli society for Tuberculosis and mycobacterial diseases, Management board member: EMBARC, Editorial board member: ERJ, Chest, and ERJ taskforce- bronchiectasis guidelines, disclosures made outside the submitted work; Receipt of oPEP devices for clinical trial from Trudell medical international, outside the submitted work.

Conflict of interest: James D Chalmers reports grants or contracts from Astrazeneca, Genentech, Gilead Sciences, Glaxosmithkline, Insmed, Grifols, Novartis, and Boehringer Ingelheim, outside the submitted work; consulting fees from Astrazeneca, Chiesi, Glaxosmithkline, Insmed, Grifols, Novartis, Boehringer Ingelheim, Pfizer, Janssen, Antabio, Zambon, outside the submitted work.